[1] Hudson, P.L., Toye, C. and Kristjanson, L.J. (2006) Would People with Parkinson’s Disease Benefit from Palliative Care? Palliative Medicine, 20, 87-94.
http://dx.doi.org/10.1191/0269216306pm1108oa
[2] Liao, S. and Arnold, R.M. (2007) Attitudinal Differences in Neurodegenerative Disorders. Journal of Palliative Medicine, 10, 430-432.
http://dx.doi.org/10.1089/jpm.2006.9979
[3] Deaths, Percent of Total Deaths, and Death Rates for the 15 Leading Causes of Death: United States and Each State, 1999-2014.
http://www.cdc.gov/nchs/nvss/mortality/lcwk9.htm
[4] Elman, L.B., Houghton, D.J., Wu, G.F., Hurtig, H.I., Markowitz, C.E. and McCluskey, L. (2007) Palliative Care in Amyotrophic Lateral Sclerosis, Parkinson’s Disease, and Multiple Sclerosis. Journal of Palliative Medicine, 10, 433-457.
http://dx.doi.org/10.1089/jpm.2006.9978
[5] Kelley, A.S. and Morrison, R.S. (2015) Palliative Care for the Seriously Ill. New England Journal of Medicine, 373, 747-755.
http://dx.doi.org/10.1056/NEJMra1404684
[6] Palliative Care in Neurology. The American Academy of Neurology Ethics and Humanities Subcommittee. (1996) Neurology, 46, 870-872.
[7] Boersma, I., Miyasaki, J., Kutner, J. and Kluger, B. (2014) Palliative Care and Neurology: Time for a Paradigm Shift. Neurology, 83, 561-567.
http://dx.doi.org/10.1212/WNL.0000000000000674
[8] WHO Definition of Palliative Care
http://www.who.int/cancer/palliative/definition/en/
[9] Miyasaki, J.M., Long, J., Mancini, D., Moro, E., Fox, S.H., Lang, A.E., et al. (2012) Palliative Care for Advanced Parkinson Disease: An Interdisciplinary Clinic and New Scale, the ESAS-PD. Parkinsonism & Related Disorders, 18, S6-S9.
http://dx.doi.org/10.1016/j.parkreldis.2012.06.013
[10] Saleem, T.Z., Higginson, I.J., Chaudhuri, K.R., Martin, A., Burman, R. and Leigh, P.N. (2013) Symptom Prevalence, Severity and Palliative Care Needs Assessment Using the Palliative Outcome Scale: A Cross-Sectional Study of Patients with Parkinson’s Disease and Related Neurological Conditions. Palliative Medicine, 27, 722-731.
http://dx.doi.org/10.1177/0269216312465783
[11] Goy, E.R., Carter, J. and Ganzini, L. (2008) Neurologic Disease at the End of Life: Caregiver Descriptions of Parkinson Disease and Amyotrophic Lateral Sclerosis. Journal of Palliative Medicine, 11, 548-554.
http://dx.doi.org/10.1089/jpm.2007.0258
[12] Snell, K., Pennington, S., Lee, M. and Walker, R. (2009) The Place of Death in Parkinson’s Disease. Age and Ageing, 38, 617-619.
http://dx.doi.org/10.1093/ageing/afp123
[13] Hasson, F., Kernohan, W.G., McLaughlin, M., Waldron, M., McLaughlin, D., Chambers, H. and Cochrane, B. (2010) An Exploration into the Palliative and End-Of-Life Experiences of Carers of People with Parkinson’s Disease. Palliative Medicine, 24, 731-736.
http://dx.doi.org/10.1177/0269216310371414
[14] Giles, S and Miyasaki, J. (2009) Palliative Stage Parkinson’s Disease: Patient and Family Experiences of Health-care Services. Palliative Medicine, 23, 120-125.
http://dx.doi.org/10.1177/0269216308100773
[15] Carver, A.C., Vickrey, B.G., Bernat, J.L., Keran, C., Ringel, S.P. and Foley, K.M. (1999) End-of-Life Care: A Survey of US Neurologists’ Attitudes, Behavior, and Knowledge. Neurology, 53, 284-284.
http://dx.doi.org/10.1212/wnl.53.2.284
[16] Dallara, A. and Tolchin, D.W. (2014) Emerging Subspecialties in Neurology: Palliative Care. Neurology, 82, 640-642.
http://dx.doi.org/10.1212/WNL.0000000000000121
[17] Hanratty, B., Hibbert, D., Mair, F., May, C., Ward, C., Corcoran, G., Litva, A., et al. (2006) Doctors’ Understanding of Palliative Care. Palliative Medicine, 20, 493-497.
http://dx.doi.org/10.1191/0269216306pm1162oa
[18] Turner-Stokes, L., Sykes, N., Silber, E., Khatri, A., Sutton, L. and Young, E. (2007) From Diagnosis To Death: Exploring the Interface between Neurology, Rehabilitation and Palliative Care in Managing People with Long-Term Neurological Conditions. Clinical Medicine, 7, 129-136.
http://dx.doi.org/10.7861/clinmedicine.7-2-129
[19] Ghoche, R. (2012) The Conceptual Framework of Palliative Care Applied to Advanced Parkinson’s Disease. Parkinsonism & Related Disorders, 18, S2-S5.
http://dx.doi.org/10.1016/j.parkreldis.2012.06.012
[20] Ford, B. (2010) Pain in Parkinson’s Disease. Movement Disorders, 25, S98-S103.
http://dx.doi.org/10.1002/mds.22716
[21] Cohen, S.M., Elackattu, A., Noordzij, J.P., Walsh, M.J. and Langmore, S.E. (2009) Palliative Treatment of Dysphonia and Dysarthria. Otolaryngologic Clinics of North America, 42, 107-121.
http://dx.doi.org/10.1016/j.otc.2008.09.010
[22] Fleisher, J.E. and Stern, M.B. (2013) Medication Nonadherence in Parkinson’s Disease. Current Neurology and Neuroscience Reports, 13, 382.
http://dx.doi.org/10.1007/s11910-013-0382-z
[23] Bunting-Perry, L.K. (2006) Palliative Care in Parkinson's Disease: Implications for Neuroscience Nursing. Journal of Neuroscience Nursing, 38, 106-113.
http://dx.doi.org/10.1097/01376517-200604000-00006
[24] Silveira, M.J., Kim, S.Y.H. and Langa, K.M. (2010) Advance Directives and Outcomes of Surrogate Decision Making before Death. New England Journal of Medicine, 362, 1211-1218.
http://dx.doi.org/10.1056/NEJMsa0907901
[25] Kwak, J., Wallendal, M.S., Fritsch, T., Leo, G. and Hyde, T. (2014) Advance Care Planning and Proxy Decision Making for Patients with Advanced Parkinson Disease. Southern Medical Journal, 107, 178-185.
http://dx.doi.org/10.1097/SMJ.0000000000000075
[26] Advance Care Planning (N.D.)
http://www.caringinfo.org/i4a/pages/index.cfm?pageid=3277
[27] NHS Choices (N.D.) End of Life Care Guide: Planning Ahead for Your Care.
http://www.nhs.uk/Planners/end-of-life-care/Pages/planning-ahead.aspx
[28] Lanoix, M. (2009) Palliative Care and Parkinson’s Disease: Managing the Chronic-Palliative Interface. Chronic Illness, 5, 46-55.
http://dx.doi.org/10.1177/1742395309102819
[29] Miyasaki, J.M. (2013) Palliative Care in Parkinson’s Disease. Current Neurology and Neuroscience Reports, 13, 367.
http://dx.doi.org/10.1007/s11910-013-0367-y
[30] Gort, A.M., Mingot, M., Gomez, X., Soler, T., Torres, G., Sacristán, O., Cabau, J., et al. (2007) Use of the Zarit Scale for Assessing Caregiver Burden and Collapse in Caregiving at Home in Dementias. International Journal of Geriatric Psychiatry, 22, 957-962.
http://dx.doi.org/10.1002/gps.1770
[31] Ellis, T., de Goede, C.J., Feldman, R.G., Wolters, E.C., Kwakkel, G. and Wagenaar, R.C. (2005) Efficacy of a Physical Therapy Program in Patients with Parkinson’s Disease: A Randomized Controlled Trial. Archives of Physical Medicine and Rehabilitation, 86, 626-632.
http://dx.doi.org/10.1016/j.apmr.2004.08.008
[32] Suchowersky, O., Gronseth, G., Perlmutter, J., Reich, S., Zesiewicz, T. and Weiner, W.J. (2006) Practice Parameter: Neuroprotective Strategies and Alternative Therapies for Parkinson Disease (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 66, 976-982.
http://dx.doi.org/10.1212/01.wnl.0000206363.57955.1b
[33] Borasio, G.D. (2013) The Role of Palliative Care in Patients with Neurological Diseases. Nature Reviews Neurology, 9, 292-295.
http://dx.doi.org/10.1038/nrneurol.2013.49
[34] Cheng, E.M., Tonn, S., Swain-Eng, R., Factor, S.A., Weiner, W.J., Bever, C.T. and For the American Academy of Neurology Parkinson Disease Measure Development Panel (2010) Quality Improvement in Neurology: AAN Parkinson Disease Quality Measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology, 75, 2021-2027.
http://dx.doi.org/10.1212/WNL.0b013e3181ff96dd
[35] Goy, E.R., Bohlig, A., Carter, J. and Ganzini, L. (2015) Identifying Predictors of Hospice Eligibility in Patients with Parkinson Disease. American Journal of Hospice and Palliative Medicine, 32, 29-33.
http://dx.doi.org/10.1177/1049909113502119